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Background/aim: The effect of testosterone replacement therapy was investigated on bladder functions, histology, apoptosis as well as
Rho-kinase expression in the rat bladder outlet obstruction (BOO) and hypogonadism models.
Materials and methods: 30 mature male rats divided into 4 groups: sham group (n = 8), BOO group (n = 8), BOO + orchiectomy group
(n = 7), BOO + orchiectomy + testosterone (T) treatment group (n = 7). Cystometric findings, apoptosis index, Rho-kinase (ROCK-2)
expression, and smooth muscle/collagen ratio were compared.
Results: BOO did not change ROCK-2 expression level, compared to sham group (P > 0.05). However, when compared to BOO group
(P < 0.01), BOO + orchiectomy led ROCK-2 increase. The testosterone treatment failed to reverse the up-regulation of ROCK-2 induced
by orchiectomy although it tended to lower ROCK-2 level. Compared to sham group (P = 0.002), changes in maximal bladder capacity
and leak point pressure were higher (P = 0.026, P = 0.001), and bladder compliance was lower in BOO group. Also, the apoptosis index
was different between the two groups (P = 0.380). Smooth muscle/collagen ratio was higher in BOO + orchiectomy + T group than in
BOO + orchiectomy group (P = 0.010).
Conclusions: The research draws attention to alternating treatment approaches in case of the presence of hypogonadism and BOO.
Key words: Bladder, rho-kinase expression, hypogonadism, apoptosis, bladder outlet obstruction

1. Introduction
Benign prostatic hyperplasia (BPH) is a disorder that can
cause bladder outlet obstruction (BOO). BPH is the most
important pathological condition that contributes to lower
urinary tract symptoms (LUTS). LUTS increases with age
and its prevalence above 50 years is approximately 50%.
Two-thirds of men with BPH experience symptoms of
overactive bladder (OAB). BOO causes detrusor smooth
muscle (DSM) hypertrophy in the bladder, which leads
to impaired bladder storage and voiding ability. After
pharmacological or surgical treatment of BOO, OAB
symptoms may still persist in 38% of men [1,2].
Smooth muscle structure and function changes
significantly after BOO. Failure of the bladder to adapt to
BOO is the main reason for reduced bladder contraction
function [3]. Adequate smooth muscle and collagen
content and their ratio in bladder interstitium are important
for bladder function. Smooth muscle contractions of the

bladder are regulated by intracellular Ca2+ concentration.
Increased intracellular Ca2+ concentration causes
calmodulin-mediated activation of myosin light chain
kinase (MLCK), which causes smooth muscle contraction.
In addition to the calcium-dependent pathway, the Rhokinase pathway, a calcium-independent pathway, has
gained importance in smooth muscle contraction [4].
Rho-kinase (ROCK) is a serine/threonine protein with
two isoforms: ROCK α and ROCK β. It has been proven
that the Rho-kinase pathway plays an important role in
the regulation of bladder smooth muscle contraction and
tone. Activated ROCK phosphorylates and deactivates
smooth muscle myosin phosphatase, which prevents
phosphorylation of myosin light chain kinase, which
leads to Ca2+ sensitization of smooth muscle [5]. ROCK
is one of the main mediators for muscle contraction and
relaxation responses. The important role of ROCK protein
in expression and smooth muscle cell contraction has been
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demonstrated in cavernous bodies, ureters, bladder, and
vas deferens [6]. In BOO, detrusor muscle hypertrophy
occurs, and ROCK expression increases [7].
Androgen deficiency is a condition that causes
urogenital dysfunction in older men. In symptomatic lateonset hypogonadism (SLOH), testosterone replacement
therapy can lead to prostate enlargement and consequently
LUTS [8]. Testosterone replacement therapy is indicated
in the presence of clinical symptoms suggestive of
hormone deficiency and decreased testosterone level [9].
The aim of this study is to investigate the effect of Rhokinase expression and testosterone replacement therapy
on bladder functions, histology, apoptosis and Rho-kinase
expression in BOO and hypogonadism rat model.
2. Materials and methods
The experimental protocol was approved by the ethical
committee on Animal Research at the University of
Mersin School of Medicine (Approval No: 200917). A total
of 30 Wistar-albino rats were included in the study and
divided into 4 groups. The rats weighed 200–250 g and
were 30 days old. The sham group (n = 8) included sham
operated rats; BOO was performed in the BOO group (n
= 8) and BOO and bilateral orchiectomy in the BOO +
orchiectomy group (n = 7). In the BOO + orchiectomy
+ T treatment group, rats were given intramuscular
injection of 100 mg/kg testosterone undecanoate (Nebido,
Bayer Schering Pharma, Berlin, Germany) after bladder
outlet obstruction and bilateral orchiectomy (n = 7). In
all groups, urodynamic evaluations were performed to
determine bladder pressures, capacities and compliance at
the beginning of the study and 2 months later. At the end
of the study, after the rats were sacrified, smooth muscle
collagen ratios and apoptosis indices were studied. Rhokinase (ROCK-2) protein expression in bladder tissue was
determined by Western blot analysis.
2.1. Surgical model of bladder outlet obstruction
Under sterile conditions, moderate prostatic urethral
obstruction was created in all rats by retropubic approach
after anesthetic induction with ketamine (80–100 mg/kg
i.p.). 150 mg/kg ampicillin i.m was given for prophylaxis
before the procedure. The urinary bladder was reached
with a 2 cm midline incision and the prostatic urethra
was carefully isolated. To create a partial occlusion of
the urethra, a 0.91 mm sterile metal rod was attached
around the prostatic urethra with 3–0 polypropylene
nonabsorbable suture, and when the suture was fixed, the
metal rod was slowly removed. The upper muscle layers
were brought closer with 4–0 silk suture. The skin was
then closed, and the incision was cleaned with povidoneiodine. Rats were placed in a cage under a heating lamp
after surgery.
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2.2. Functional evaluation
Urodynamic studies were performed at the beginning and
end of the study just before the rats were sacrified [10]. After
the midline incision was made under ketamine anesthesia
(50 mg/kg i.m.), the 22 - G catheter was placed directly in
the dome of the bladder and the residual urine was emptied.
The catheter was connected to a pressure transducer using
urodynamic equipment with a polyethylene tube, and
urodynamics were performed by infusing a heated (37
°C) normal saline solution at 0.15 mL/min. Urodynamic
studies were performed at the beginning and end of the
study in each rat. The baseline (empty bladder), opening
(at the first leakage), and peak pressure (maximal pressure
during voiding) and the maximal bladder capacity were
recorded during the study. Bladder compliance (ml/cm
H2O) was calculated according to the following formula:
Compliance = Maximal Bladder Volume / Opening
Pressure–Baseline Pressure.
2.3. Western blot analysis for ROCK-2
Rat bladder tissues were homogenized with a lysis buffer
(composition in mM; Tris–HCl (pH = 7.4) 50 mM, NaCl
400 mM, EGTA 2 mM, EDTA 1 mM, dithiothreitol 1
mM, phenylmethylsulfonyl fluoride 10 μM, leupeptin
10 μg/ml, pepstatin 1 μg/ml, benzamidine 1 mM). The
homogenate was centrifuged at 13,000 × g for 10 min at 4
°C, and the supernatant was removed. It was then used for
protein analysis (with Bradford method) and Western blot
analysis [11]. Equal amounts of the protein (75 μg) were
loaded in wells, electrophoresed on 8% polyacrylamide–
sodium dodecyl sulphate (SDS) gels and then transferred
to a nitrocellulose membrane overnight. The membrane
was blocked with the blocking agent of the enhanced
chemiluminescence (ECL advance) kit (Amersham
Biosciences, Freiburg, Germany) in Tris-buffered solution
containing 0.05% Tween 20 for 1 h. It was then probed
with a primary antibody raised against ROCK-2 (ROCKα,
Mouse monoclonal IgG, BD Science, USA) at 1: 2000
dilution followed by a horseradish peroxidase (HRP)
- conjugated secondary antibody (donkey antimouse,
1: 2000, Santa Cruz Biotechnology Inc. CA, USA).
Protein blots were then detected with the advanced
chemiluminescence detection kit (Amersham Biosciences,
Freiburg, Germany) and visualized on commercial X-ray
film.
2.4. Histologic evaluation
In paraffin sections (5 μm), bladder tissues were placed
and encoloured with Masson’s trichrome for the
assessment of smooth muscle/collagen content. The
sections were assessed using light microscopy at 400 hpf.,
and intended areas were photographed. The muscularis
propria was encoloured red, and the collagen deposition
of intrafascicular and perifascicular zone of the muscularis
propria was encoloured using green light. The muscle ratio
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of the rats and the collagen tissue deposition were evaluated
as 1unit fibrosis and 3units muscle: mild blockage (1), 2
unit fibrosis and 2 unit muscle: moderate blockage (2),

and 3 unit fibrosis and 1 unit muscle: marked blockage
(3). Histologic pictures of the bladder mucosa (Figure 1a1,
Figure 1b1, Figure 1c1, and Figure 1d1), smooth muscle

Figure 1a. Histological sections shows a regular bladder muscle thickness in the sham group. A slightly increased ratio in favor of
muscle is observed histologically (a1: H-E, ×40). By the Masson’s trichrome stain, fibrous tissue (green and marked with a small arrow)
and regular muscle tissue (red and marked with a long arrow) were seen (a2; Masson Trichrome, ×40). The number of apoptotic cells
per unit focus in the whole epithelial lining area were shown immunohistochemically. The determined apoptotic cells were 6–8 (arrow)
in a high power field (HPF), microscopically. (a3: Tunnel, ×400). 1b. Histological sections shows minimally increased bladder muscle
in the BOO group. A slightly increased muscle fibers were observed (b1: H-E, ×40). The minimally increased fibrous tissue (green and
marked with a small arrow) around perifascicular and intrafascicular area and minimally increased muscle tissue (red and marked with
a long arrow) were seen by Masson’s trichrome stain (b2; Masson Trichrome, ×40). The determined apoptotic cells were 7–8 (arrow) in a
high-power field (HPF) immunohistochemically (b3: Tunnel, ×400). 1c. Histological picture shows a partially increased regular bladder
muscle thickness in the BOO + orchiectomy group (c1; H-E, ×40). With Masson’s trichrome stain, fibrous tissue (green and marked with
a small arrow) is observed in muscle tissue (red and marked with a long arrow) in a slightly increased ratio (c2; Masson Trichrome, x40).
The number of apoptotic cells (7-8/ HPF) (arrow) do not show a significant difference in the form of sham group (7-8/HPF) (c3: Tunnel,
×400). 1d. The image shows a markedly thickened bladder muscle in the BOO + orchiectomy+ treatment group (d1; H-E, ×40). When
compared with Masson’s trichrome stain, especially in Figure 1a, fibrous tissue (in green color) is quite rare and a markedly increased
irregular muscle fibers (in red color) were observed (d2; Masson Trichrome, ×40). The number of apoptotic cells were observed by
immunohistochemistry does not show a significant difference. Apoptotic epithelial cell count is 7–8/5 HPFs (arrow) (d3: Tunnel, ×400).
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and collagen tissue deposition of all groups were shown in
Figure 1a2, Figure 1b2, Figure 1c2, and Figure 1d2.
For detection of apoptosis, the terminal
deoxynucleotidyl transferase-mediated dUTP-nick end
labelling (TUNNEL) method was employed, histologic
pictures of apoptotic cells were shown in Figure 1a3, Figure
1b3, Figure1c3, and Figure 1d3. In brief, 5 μm density
of tissue sectors were deparaffinized and rehydrated in a
graded series of xylene and ethanol. The staining progress
was monitored with the help of a microscope right after
the encolouring by 0.05% diaminobenzidine in staining
buffer. The zone with the highest number of apoptotic cells
was chosen at five high-power (× 400) branches. Next, 100
cells were regarded, and the apoptotic index was described
as the ratio of the apoptotic cells to the normal epithelial
cells in a dedicated zone.
2.5. Statistical analysis
Statistical analyses were performed using the “one way
ANOVA test” to compare the mean body weight and mean
serum testosterone level at the beginning and end of the
experiment among the groups, “independent t–test” to
compare smooth muscle collagen ratio and differences
as percentage in cystometric findings at the beginning
and end of each experiment between the 2 groups. Data
are presented as a mean ± standard deviation for the
smooth muscle/collagen ratio. Probability values of <0.05
were considered statistically significant. For Westernblot analysis, all data represent mean ± standard errors
of the mean (S.E.M.) of n observations. Shapiro–Wilk
as normality test was performed all parameters and
comparing two or more groups. All parameters and

groups were in normal distribution (P values >0.005,
95% confidence interval), and we used parametric tests.
For statistical comparison, analysis of variance (ANOVA)
followed by Bonferroni’s multiple comparison test was
used. A P value of less than 0.05 was considered significant.
Graphs were drawn by the use of a GraphPad Prism 3.0
program (GraphPad Software, San Diego, CA, USA).
3. Results
As shown in Table 1, there were no differences in the
mean body weight and total testosterone level at baseline
among the groups. From the beginning to the end of the
experiment, no significant differences in the mean weight
were seen in the BOO and BOO + orchiectomy groups;
however, the mean body weight significantly increased in
the sham and BOO + orchiectomy + T treatment groups
(P < 0.001 and P < 0.001, respectively). The mean serum
total testosterone level did not change in the sham, BOO
and BOO + orchiectomy + T treatment groups; however,
it significantly decreased in the BOO + orchiectomy group
form the beginning to the end of the experiment (P =
0.001).
As shown in Figure 2, ROCK-2 expression did not
change significantly in the BOO group, compared with
the sham group (P > 0.05). However, in the BOO +
orchiectomy group, ROCK-2 expression significantly
increased compared to the BOO group (P < 0.01). I.m.
testosterone treatment added after BOO + orchiectomy
failed to reverse the up-regulation of ROCK-2 observed
in the BOO + orchiectomy group although ROCK-2 level
tended to decrease.

Table 1. Mean weight, total testosterone level, and cystometric findings (maximal bladder capasity, leak point pressure and compliance)
of the rats from the beginning to the end of the experiment in all groups.
Sham group
(n = 8)
233.88 ± 4.67
264.50 ± 5.26
(P < 0.001)
0.507 ± 0.042
Basal total testosterone
0.503 ± 0.024
Last total testosterone (ng/mL)
(P = 0.676)
0.61 ± 0.14
Basal max. bladder capasity
0.85 ± 0.10
Last max. bladder capasity (ml)
(P = 0.004)
28.88 ± 5.59
Basal leak point pressure
36.25 ± 4.27
Last leak point pressure (cmH2O)
(P = 0.029)
0.021 ± 0.002
Basal compliance
0.023 ± 0.003
Last compliance (ml/cmH2O)
(P = 0.044)
Basal weight
Last weight (g)
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BOO group
(n = 8)
234.88 ± 5.19
240.38 ± 8.67
(P = 0.059)
0.519 ± 0.034
0.509 ± 0.042
(P = 0.086)
0.59 ± 0.14
1.10 ± 0.95
(P = 0.001)
29.50 ± 5.29
60.38 ± 6.14
(P = 0.001)
0.020 ± 0.002
0.018 ± 0.001
(P = 0.024)

BOO + orchiectomy
group
(n = 7)
230.14 ± 6.20
229.14 ± 5.37
(P = 0.582)
0.505 ± 0.034
0.002 ± 0.001
(P = 0.001)
0.60 ± 0.21
1.20 ± 0.11
(P = 0.001)
30.43 ± 4.24
69.57 ± 1.51
(P = 0.001)
0.019 ± 0.004
0.017 ± 0.002
(P = 0.045)

BOO + orchiectomy + T
treatment group
(n = 7)
232.00 ± 5.13
261.71 ± 7.78
(P < 0.001)
0.513 ± 0.021
0.514 ± 0.014
(P = 0.889)
0.60 ± 0.18
1.01 ± 0.12
(P = 0.003)
30.86 ± 3.34
59.14 ± 5.21
(P = 0.001)
0.019 ± 0.004
0.018 ± 0.002
(P = 0.193)
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Figure 2. Rho kinase expression in all groups. ROCKII expression was measured by western-blotting. Density of bants
was analyzed with Scion Image program. Data represent mean ± standard errors of the mean (S.E.M.) of n observations.
For statistical comparison, analysis of variance (ANOVA) followed by Bonferroni’s multiple comparison test was used.
**P<0.01 (BOO versus BOO+orchiectomy).

Figure 3 shows maximal bladder capacity and
compliance from the beginning to the end of the experiment
in all groups with the changes as percentages also as shown
in Table 2. Changes in maximal bladder capacity and leak
point pressure were higher in the BOO group than in the
sham group (P = 0.026 and P = 0.001, respectively). Change
in bladder compliance was lower in the BOO group,
compared with the sham group (P = 0.002). However,
the apoptosis index did not differ significantly between
the two groups (P = 0.380). Changes in maximal bladder
capacity and bladder compliance did not differ between
the BOO + orchiectomy and BOO + orchiectomy + T
treatment groups (P = 0.247 and P = 0.539, respectively).
However, leak point pressure significantly more decreased
in the BOO + orchiectomy + T treatment group than in
the BOO + orchiectomy group (P = 0.045). In addition,
the smooth muscle/collagen ratio was higher in the BOO
+ orchiectomy + T treatment group than in the BOO +
orchiectomy group (P = 0.01). The total apoptosis index
was lower in the BOO + orchiectomy + T treatment group
than in the BOO + orchiectomy group, but the difference
was not statistically significant (P = 0.181).
4. Discussion
In this study, we investigated effects of testosterone
undecanoate therapy on the ROCK-2 expression and

bladder behavior in the rat BOO and hypogonadism
models. Smooth muscle system and function were
essentially changed following BOO [3]. One of the main
reasons that the bladder contraction function decreases is
the inability to adapt to BOO [7]. That ROCK has a critical
function in the organization of rat urinary bladder smooth
muscle contraction and tone have been shown by most
studies. ROCK enzymes are highly expressed in rat urinary
bladder smooth muscle, and the selective ROCK inhibitor
Y-27632 attenuates contractions [7]. Based on this, we
analyzed differences in ROCK-2 expression following a
model of BOO. Compared with the sham group, we came
to the conclusion that ROCK-2 expression did not change
meaningfully in the BOO group for two weeks. In a former
study on the expression of ROCK isoforms in BOO rabbits,
Bing et al. indicated that in mature male rabbits, ROCK α
(ROCK-2) did not differ, supporting our data. However, in
that study, ROCK β (ROCK-1) was overexpressed in the
smooth muscle in response to BOO.
Our research is different in terms of the time course
of obstruction. Besides, the antibody usage and the level
of obstruction performed may differ [2]. There is no data
on the relationship between ageing and ROCK expression
in the bladder tissue. Observations have shown that the
structural proteins of the cytoskeleton, and its connection
to the extracellular matrix with the plasma membrane
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Figure 3. Mean maximal bladder capacity (A) and bladder compliance (B) from the beginning to the end of the experiment in all
groups.
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Table 2. Changes as percentage in cystometric findings (maximal bladder capasity, leak point pressure and compliance) from the
beginning to the end of the study and mean smooth muscle/collagen ratio and total apoptosis index at sacrification in all groups.

Change in maximal bladder
capacity (%)
Change in leak point
pressure (%)
Change in bladder
Compliance (%)
Smooth muscle/collagen ratio
Total apoptosis index

Sham group
(n = 8)

BOO group
(n = 8)

BOO + orchiectomy group
(n = 7)

BOO + orchiectomy + T
treatment group
(n = 7)

42.60

96.46

112.87

80.22

29.26

110.65

131.68

94.78

9.10

–10.07

–11.67

–7.17

2.80 ± 0.84

3.20 ± 0.76

1.90 ± 0.65

3.30 ± 0.67

1.80 ± 1.30

3.24 ± 3.21

6.00 ± 3.16

3.60 ± 1.85

are dynamically regulated and play an important role in
contraction responses, as well as accompanying bladder
contraction with cyclic ischemia/reperfusion (I/R). The
severity of ischemia/reperfusion increases in the presence
of increasing bladder thickness. Age related intolerance
to cyclical I/R may cause activation of ROCK signaling
[12]. In support, unilateral obstruction of rabbit ureter, the
expression levels of ROCK-1 and ROCK-2 dramatically
up-regulated, implicating that Rho/ROCK signaling
pathway may be an important therapeutic target in for
the treatment of particular urogenital diseases [13]. SLOH
is associated with advancing age and characterized by
typical symptoms and a deficiency in serum testosterone
levels. Orchiectomized rats have been used as a model of
testosterone deficiency due to hypogonadism [14]. However,
SLOH is a condition characterized by a combination of
central and peripheral hypogonadism. Surgical castration
is a pure model of peripheral hypogonadism, and may not
be an appropriate model of SLOH in human. In the present
study, we performed BOO and bilateral orchiectomy, and
then we investigated the effect of testosterone replacement
therapy on bladder functions and smooth muscle/collagen
content in orchiectomized mature male rats.
Our experimental rat study showed that bladder
capacity and smooth muscle/collagen content may decrease
in the presence of testosterone deficiency. Androgens
can stimulate stromal precursor cells differentiation into
smooth muscle cells through the activation of androgen
receptors. In their study, Lin et al. showed that the number of
vessels, epithelial thickness, and muscle fibers increased in
the bladder of rats receiving androgen/estrogen compared
to the bladders of rats receiving isolated conjugated
estrogen [15]. Few studies have reported that androgens
also regulate growth and differentiation of vascular
smooth muscle cells in bladder tissue [9]. Therefore,
we investigated the effect of testosterone treatment on

bladder functions and smooth muscle/collagen content in
castrated adult rats. Androgen deprivation can interfere
with smooth muscle differentiation. In this study, after
performing orchiectomy we showed that bladder capacity
and smooth muscle content decreased. Furthermore,
following orchiectomy ROCK-2 expression increased
significantly, but testosterone treatment failed to reverse
this up-regulation although there was a tendency in
ROCK-2 expression to decrease, which was not found to
be significant.
In our study, increases in maximum bladder capacity
were significantly higher in the BOO group than in the
sham group. In addition, the leak point pressure was higher
in the BOO group than the sham group, and the difference
was statistically significant. Bladder compliance was lower
in the BOO group when compared with the sham group.
Apoptotic indexes did not change in the sham group and in
the BOO group. In the BOO + orchiectomy + T treatment
group, maximal bladder capacity, and bladder compliance
did not change. Leak point pressure decreased in the BOO
+ orchiectomy + T treatment group. In addition, smooth
muscle/collagen ratio increased, and apoptosis indexes did
not change in the bladder tissue.
A recent study of male rabbits showed that after
testosterone injection, bladder capacity, and compliance
increased blood testosterone levels in male rabbits
undergoing bilateral orchiectomy [16]. These animal
studies suggest that bladder dysfunction may be associated
with androgen deficiency, and testosterone therapy can
improve bladder function and smooth muscle/collagen
ratio in orchiectomized animals.
Testosterone has been shown to cause occlusion with
or without unstable detrusor contractions and may also
cause changes in the voiding reflex. Maggi et al. treated
adult male rats with daily injections of testosterone
and measured bladder function [17]. They found that
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testosterone therapy may cause BOO, with increased
residual urine volume and detrusor instability and without
much change in bladder capacity. In another study by
Pandita et al., testosterone treatment for 2 weeks increased
prostate weight in adult male rats [18]. The enlargement
of the prostate gland in response to androgen therapy can
cause obstruction. However, in the present study, we used
testosterone in the orchiectomized rats and normal range
levels of testosterone achieved with testosterone therapy
did not stimulate prostate growth to volumes greater than
those measured during prior therapy. It has been reported
that ROCK is involved in the pathophysiology of OAB
symptoms induced by hypertension and diabetes [19].
Consequently, this study showed the relationship
between testosterone and Rho-kinase-2 expression and
hypogonadism rat model in BOO. ROCK-2 expression
increased significantly after orchiectomy in bladder
tissues, which was not significantly restored by testosterone
replacement treatment. We suggest that, in hypogonadism,
testosterone treatment has a substantial influence on
BOO-induced detrusor overactivity without significantly

change in ROCK-2 upregulation. Based on these results
(e.g., up-regulation of ROCK-2 following bladder
obstruction and orchiectomy), alternative treatment
modalities might be considered, such as the use of ROCK
inhibitors or/and testosterone replacement. However,
further studies are needed to support these mechanisms
related to testosterone treatment with ROCK inhibition in
hypogonadism and its prevention of detrusor hypertrophy
and detrusor overactivity.
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